Sequent Scientific has informed that the Nomination and Remuneration Committee of the Board of Directors of the Company has granted 100,000 stock options to the employees of the Company. These options are to be vested over a period of 4 years at the rate of 25% per year and the exercise price per option will be Rs 435. These options are convertible into equivalent number of equity shares of the Company having face value of Rs 10 each.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1862.55 |
| Dr. Reddys Lab | 1278.20 |
| Cipla | 1296.95 |
| Zydus Lifesciences | 940.20 |
| Lupin | 2274.55 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: